BIOXCEL THERAPEUTICS INC's ticker is BTAI and the CUSIP is 09075P105. A total of 96 filers reported holding BIOXCEL THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 1.24 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $3,810,633 | -29.0% | 204,214 | -18.3% | 0.86% | -33.3% |
| Q4 2022 | $5,370,000 | +4652.2% | 250,000 | +4505.7% | 1.30% | +8540.0% |
| Q1 2022 | $113,000 | +8.7% | 5,428 | +5.1% | 0.02% | 0.0% |
| Q4 2021 | $104,000 | -98.4% | 5,167 | -96.7% | 0.02% | -93.4% |
| Q1 2021 | $6,700,000 | -3.3% | 155,232 | +3.5% | 0.23% | -26.1% |
| Q4 2020 | $6,930,000 | +4.7% | 150,000 | -1.8% | 0.31% | -36.1% |
| Q3 2020 | $6,621,000 | -70.1% | 152,714 | -63.4% | 0.48% | -72.8% |
| Q2 2020 | $22,138,000 | +24.3% | 417,618 | -47.6% | 1.76% | +31.5% |
| Q1 2020 | $17,814,000 | +669.8% | 797,016 | +403.3% | 1.34% | +257.3% |
| Q4 2019 | $2,314,000 | – | 158,373 | – | 0.38% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 430,000 | $19,866,000 | 1.70% |
| APIS CAPITAL ADVISORS, LLC | 20,000 | $924,000 | 0.89% |
| Avidity Partners Management LP | 547,000 | $25,271,000 | 0.82% |
| Knoll Capital Management, LLC | 20,000 | $924,000 | 0.63% |
| Artemis Investment Management LLP | 1,013,448 | $46,839,000 | 0.49% |
| AlphaCentric Advisors LLC | 25,000 | $1,155,000 | 0.48% |
| First Light Asset Management, LLC | 94,202 | $4,352,000 | 0.32% |
| Ikarian Capital, LLC | 150,000 | $6,930,000 | 0.31% |
| Longitude (Cayman) Ltd. | 8,000 | $370,000 | 0.18% |
| AllSquare Wealth Management LLC | 5,490 | $254,000 | 0.17% |